Researchers from Boston Children's Hospital and MIT are collaborating on a new approach to treating amyotrophic lateral sclerosis (ALS). They aim to develop RNA-based treatments by combining the strengths of both institutions' research toolkits. This collaboration may lead to more effective therapies for ALS, which currently has limited treatment options. --- Why it matters: This matters because it could bring new hope to patients with ALS, a devastating neurodegenerative disease with no cure. The collaboration's focus on RNA-based treatments is particularly promising, as this approach has shown potential in other neurological disorders. Source: https://deepmind.google/blog/uniting-biological-toolkits-for-a-new-approach-to-als/